Procedures using surgical matrices continued their recovery and companies have resumed investing, with revenues surpassing their Q419 levels.
As the pandemic wanes and procedures are again being scheduled, the US Surgical Matrices market grew strongly in Q421, gaining +12.7% YoY according to the SmartTRAK Financial Dashboard. AbbVie continued to lead the Surgical Matrices market, with Becton Dickinson also growing well ...
Among the many topics covered in detail in our comprehensive Q421 US Surgical Matrices Market Recap* are: